1. Home
  2. Browse
  3. HRA004366
HRA004366
   HRA004366.xlsx
Title:
Genomic analysis reveals distinct molecular features between primary and relapsed/refractory natural killer/T cell lymphoma
Release date:
2023-04-14
Description:
Natural killer/T cell lymphoma (ENKTL) is a clinically and genetically heterogeneous disease that predominantly occurs in east Asia. The genomic characteristics of relapsed/refractory (R/R) ENKTL have remained largely unclear, which limit the development of target therapy for ENKTL. We performed a comprehensive genetic analysis of whole-exome sequencing between patients with primary diagnosed and R/R ENKTL to explore the different genomic alterations in the two sampling groups.
Data Accessibility:   
Controlled access Request Data
BioProject:
PRJCA015935
Study type:
Disease Study
Disease name:
mature T-cell and NK-cell lymphoma
Data Access Committee

For each controlled access study, there is a corresponding Data Access Committee(DAC) to determine the access permissions. Access to actual data files is not managed by NGDC.


DAC NO.:
HDAC002450
DAC name:
DAC for ENKTL project
Contact person:
lin tongyu
Email:
tongyulin@hotmail.com
Description:
Data Access Committee (DAC) for data release of the ENKTL project
Individuals & samples
Files
Request Data
Submitter:   lin tongyu / tongyulin@hotmail.com
Organization:   Sichuan Cancer Hospital
Submission date:   2023-04-13
Requests:   -